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INTRODUCTION 
Pleural effusion is a collection of fluid in the Pleural space .It is 
not a disease but rather a complication of an underlying illness. Effusion 
can occur for a variety of reasons. Common classification systems 
divide pleural effusions into two categories of (1) Transudative pleural 
effusions and(2) Exudative pleural effusions.  
Determining the cause of a pleural effusion is greatly facilitated 
by analysis of the pleural fluid. Thoracentesis is a simple bedside 
procedure that permits fluid to be rapidly sampled, visualized, examined 
microscopically, and quantified. A systematic approach to analysis of 
the fluid in conjunction with the clinical presentation should allow the 
clinician to diagnose the cause of an effusion. 
 A definitive diagnosis is provided by the finding of malignant 
cells or specific organisms in the pleural fluid, can be 
established in approximately 25 percent of patients. 
 Pleural effusion remains undiagnosed after routine tests in 
pleural fluid in many patients. so ,we need a simple and safe 
investigative tool to evaluate undiagnosed effusion .This study 
is designed to diagnose the cases of undiagnosed effusions by 
a simple and safe investigative tool. 
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Pleural fluid accumulates when pleural fluid formation exceeds 
pleural fluid absorption. Normally fluid enters the pleural space from the 
capillaries in the parietal pleura and is removed via the lymphatics 
situated in the parietal pleura. Fluid can also enter the pleural space from 
the interstitial spaces of the lung via the visceral pleura or from the 
peritoneal cavity via small holes in the diaphragm. The lymphatics have 
the capacity to absorb 20 times more fluid than is normally formed. 
Accordingly, a pleural effusion may develop when there is excess 
pleural fluid formation (from the interstitial spaces of the lung, the 
parietal pleura, or the peritoneal cavity) or when there is decreased fluid 
removal by the lymphatics. 
When a patient is found to have a pleural effusion, an effort 
should be made to determine the cause . The first step is to determine 
whether the effusion is a transudate or an exudate. A transudative 
pleural effusion occurs when systemic factors that influence the 
formation and absorption of pleural fluid are altered. The leading causes 
of transudative pleural effusions are left ventricular failure and cirrhosis. 
An exudative pleural effusion occurs when local factors that influence 
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the formation and absorption of pleural fluid are altered. The leading 
causes of exudative pleural effusions are Tuberculosis, bacterial 
pneumonia, malignancy, viral infection, and pulmonary embolism. The 
primary reason to make this differentiation is that additional diagnostic 
procedures are indicated with exudative effusions to define the cause of 
the local disease. 
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AIMS AND OBJECTIVES 
 
 To evaluate the role of closed Pleural biopsy in diagnosing 
exudative effusions not diagnosed by Pleural fluid analysis. 
 
 To compare the yield of each test( Histopathological 
examination , Reverse Transcriptase Polymerase Chain Reaction 
and culture for Tuberculosis by BACTEC )in Pleural biopsy 
specimens of undiagnosed exudative Effusions . 
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REVIEW OF LITERATURE 
INTRODUCTION 
 Pleural biopsy is helpful to reach an aetiological diagnosis in 
exudative pleural effusion, particularly when Malignancy is suspected or 
when the results of detailed pleural fluid study are inconclusive 
especially in a setup where Thoracoscopy is not available. 
COMMON CAUSES OF PLEURAL EFFUSION 
TRANSUDATIVE PLEURAL EFFUSIONS 
Congestive heart failure 
Cirrhosis 
Nephrotic syndrome 
Superior vena caval obstruction 
Fontan procedure 
Urinothorax 
Peritoneal dialysis 
Glomerulonephritis 
Myxedema 
Cerebrospinal fluid leaks to pleura 
Hypoalbuminemia 
Sarcoidosis 
6 
 
EXUDATIVE PLEURAL EFFUSIONS 
Neoplastic diseases 
Metastatic disease 
Mesothelioma 
Pyothorax-associated lymphoma 
Bacterial infections 
Tuberculosis 
Fungal infections 
Parasitic infections 
Viral infections 
Pulmonary embolization 
Gastrointestinal disease 
Heart diseases 
Obstetric and gynecologic disease 
Collagen vascular diseases 
Drug-induced pleural disease  
Asbestos exposure 
Sarcoidosis 
Hemothorax 
Chylothorax 
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NEEDLE BIOPSY OF THE PLEURA 
ABRAM'S NEEDLE 
 
  The Abram's needle consists of three parts: a large outer trocar,
an inner cutting cannula, and an inner solid stylet. The end of the outer
trocar is blunt so that the instrument will not lacerate the lung, but
the bluntness of the instrument requires one to make a small scalpel 
incision in the anesthetized skin and subcutaneous tissue to permit
insertion of the biopsy needle without undue force. This incision should
be made along the lines of cleavage to minimize postoperative scarring.
The inner cutting cannula fits tightly in the outer trocar and can be 
locked in one of two positions: (a) a closed position, in which the inner
cannula obstructs the notch on the outer trocar to make the needle
airtight, and (b) an open position, in which the inner cannula is slightly 
withdrawn so that the notch on the outer trocar is not occluded. An
indicator knob in the hexagonal grip of the larger outer trocar indicates
the position of the notch in the distal end of the trocar. 
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INDICATIONS 
A needle biopsy of the pleura is currently recommended when 
tuberculous pleuritis is suspected and the pleural fluid ADA or 
interferon-gamma levels are not definitive. A needle biopsy of the 
pleura is also recommended when malignancy is suspected but the 
pleural fluid cytology is negative and thoracoscopy is not readily 
available. 
With a needle biopsy of the pleura, a small piece of the parietal 
pleura is obtained for microscopic or microbiologic evaluation. The 
main diagnoses established with a needle biopsy of the pleura are 
tuberculous pleuritis and malignancy of the pleura. Currently, needle 
biopsy of the pleura is used less than in the past because the diagnosis of 
tuberculous pleuritis can be made by measuring the adenosine 
deaminase (ADA) or interferon-gamma level in the pleural fluid, and the 
diagnosis of pleural malignancy is usually established by pleural fluid 
cytology or thoracoscopy(1) . 
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CONTRAINDICATIONS 
The main contraindication to a pleural biopsy is a bleeding 
diathesis.  
Another contraindication to needle biopsies is the presence of an 
empyema(2). Other contraindications include an uncooperative patient 
and local cutaneous lesions such as pyoderma or herpes zoster infection. 
A pleural biopsy should not be performed in patients who are 
taking anticoagulants or whose bleeding parameters are prolonged. If 
the platelet count is below 50,000/mm3, platelet transfusion should be 
given before the procedure is attempted. 
 If the patient has borderline respiratory failure, one should 
hesitate to perform a pleural biopsy because the production of a 
pneumothorax could precipitate respiratory failure. 
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TECHNIQUE 
When there is a moderate or larger pleural effusion, the biopsy is 
usually done without image guidance. If the effusion is small or 
loculated, then either ultrasound or computed tomography (CT) can 
accurately identify the location of the fluid. Ultrasound is the preferred 
technique for guiding biopsy because it offers the advantage of a real-
time approach to the biopsy and has the added advantages of the 
absence of ionizing radiation, portability, ready availability, and low 
expense. Because the patient can be imaged in the erect position, the 
depth of the fluid is maximized, thereby minimizing complications(3) . 
The patient is positioned, and the site is selected as for diagnostic 
thoracentesis . The skin is cleaned, and the local anesthetic is 
administered as for diagnostic thoracentesis. Liberal amounts of 
lidocaine should be injected once the rib is passed to ensure adequate 
anesthesia of the parietal pleura. In general, if no fluid is obtained with 
the local anesthetic, biopsy should not be attempted. When pleural fluid 
has been obtained with the lidocaine syringe and needle, a pleural 
biopsy can be performed with an Abram's needle. A biopsy is 
sometimes attempted without free pleural fluid. If there is no fluid, the 
procedure should be performed with ultrasonic or CT guidance . 
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COMPLICATIONS 
Pleural biopsy has the same complications as diagnostic 
thoracentesis. One might expect pneumothorax to be more common 
with pleural biopsy than with thoracentesis for two reasons. First, the 
atmosphere has much more opportunity to be in communication with the 
pleural space with the biopsy (particularly when the Cope needle is 
used). Second, when the biopsy specimen is obtained, the visceral pleura 
may be inadvertently incised, leaving a small bronchopleural fistula that 
can lead to a large pneumothorax. However, the incidence of 
pneumothorax and the requirement for tube thoracostomy are 
comparable after thoracentesis and pleural biopsy (4). This is probably 
because more experienced individuals usually perform the pleural 
biopsy. 
The second major complication of pleural biopsy is bleeding. If 
an intercostal artery or vein is inadvertently biopsied, a hemothorax can 
result (5,6). There is one case report of an arteriovenous fistula from an 
intercostal artery to an intercostal vein developing after pleural biopsy 
(7). 
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TUBERCULOUS PLEURAL EFFUSION 
When a tuberculous pleural effusion occurs in the absence of 
radiologically apparent TB, it may be the sequel to a primary infection 6 
to 12 weeks previously or it may represent reactivation TB (8). In 
industrialized countries, more pleural effusions may be due to 
reactivation than are due to post primary infection (8). However, in a 
recent study from San Francisco, pleural TB cases were approximately 
two times more likely to be clustered (as assessed by genotyping of the 
mycobacterial organisms) than were pulmonary TB and three times 
more likely to be clustered than nonrespiratory TB cases(9). 
The tuberculous pleural effusion is thought to result from rupture 
of a subpleural caseous focus in the lung into the pleural space(10). 
Supporting evidence comes from the operative findings of Stead et 
al.(11) , who reported that they could demonstrate a caseous tuberculous 
focus in the lung contiguous with the diseased pleura in 12 of 15 
patients with tuberculous pleuritis. The remaining three patients in this 
series were found to have parenchymal TB, although these patients did 
not have caseous foci adjacent to the pleura. 
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It appears that delayed hypersensitivity plays a large role in the 
pathogenesis of tuberculous pleural effusion. The hypersensitivity 
reaction is initiated when tuberculous protein gains access to the pleural 
space. 
It is probable that delayed hypersensitivity also plays a large role 
in the development of tuberculous pleural effusions in humans. The 
mycobacterial cultures of the pleural fluid from most patients with 
tuberculous pleural effusions are negative(12,13). 
 Although delayed hypersensitivity to tuberculous protein is 
probably responsible for most clinical manifestations of tuberculous 
pleuritis, many patients when first evaluated have a negative PPD skin 
test. The explanation for this paradox may be a combination of two 
factors. First, in some(14), but not in all (15) patients with tuberculous 
pleuritis, a circulating mononuclear adherent cell suppresses the 
specifically sensitized circulating T lymphocytes in the peripheral blood. 
Second, there may be sequestration of PPD-reactive T lymphocytes in 
the pleural space involving both Leu-2 (suppressor/cytotoxic) and Leu-3 
(helper) positive T cells(15). 
14 
 
REVERSE TRANSCRIPTASE POLYMERASE CHAIN 
REACTION 
PCR is a technique to amplify a single or few copies of a piece of 
DNA across several orders of magnitude, generating millions or more 
copies of a particular DNA sequence. 
HISTORY: 
 A 1971 paper in the journal of molecular biology of Kleppe and 
co-workers first described a method using an enzymatic assay to 
replicate a short DNA template with primers in vitro. Invention of the 
PCR in 1983 is generally credited to Karry mullis. The discovery of taq 
polymerase in 1976 (DNA polymerase purified from thermophilic 
bacterium thermos aquaticus) paved the way for dramatic improvement 
of the PCR technique. Karry mullis was awarded the Nobel Prize in 
chemistry in 1993. 
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 RTPCR is an improvement from the conventional PCR and can 
detect the m-RNA of the organism under study.  
 RTPCR targeting 85 B gene is very specific for Mycobacterium 
tuberculosis, so that it is negative for Non-Tuberculous 
Mycobacterium. 
 m-RNA detected by RTPCR has a half life for only few minutes 
and can detect only viable Mycobacterium . 
BACTEC CULTURE 
The rapid radiometric culture system or BACTEC (Becton-
Dickinson) has been accepted for the culture isolation of mycobacteria 
using an enriched Middlebrook 7H12 containing 14C labeled palmitic 
acid. This medium is otherwise called BACTEC 12B. Mycobacterial 
growth is determined by the utilization of 14C with release of 14CO2 by 
the multiplying mycobacteria and is detected in an ionic chamber with 
electronic detector in the BACTEC instrument. In comparison to the 
conventional M. tuberculosis culture using Lowenstein-Jensen Media, 
the BACTEC system gives early culture results with differentiation of 
M. tuberculosis from mycobacteria other than M. 
tuberculosis(16,17,18,19). 
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MALIGNANT PLEURAL EFFUSION 
Carcinomas of the lung and breast and lymphomas account for 
approximately 75% of malignant pleural effusions . lung cancer is the 
leading cause of malignant pleural effusion (20). When patients with 
lung cancer are first evaluated, approximately 15% have a pleural 
effusion (21). 
Needle biopsy of the pleura can establish the diagnosis of a 
malignant pleural effusion. The percentage of positive pleural biopsies 
in patients with malignant pleural disease ranges from 39% to 75% 
(22,23,24). In general, pleural fluid cytology is superior to pleural 
biopsy in establishing the diagnosis of pleural malignancy. The 
diagnosis of malignancy was made in 13 of 15 patients (87%) with the 
CT-guided biopsy but in only 8 of 17 patients (47%) with the Abram's 
needle (25). 
ADENOCARCINOMA 
Adenocarcinoma of the lung is a form of non-small cell lung 
cancer. Eighty percent of lung cancers are non-small cell cancers, and of 
these, about 50% are adenocarcinomas. Adenocarcinoma of the lung 
begins in the outer parts of the lung, and it can be present for a long time 
before it is diagnosed. It is the type of lung cancer most commonly seen 
in women and is often seen in non-smokers. 
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The most common type of lung cancer in lifelong non-smokers is 
the adenocarcinoma.This cancer usually is seen peripherally in the 
lungs, as opposed to small cell lung cancer and squamous cell lung 
cancer, which both tend to be more centrally located. 
The adenocarcinoma has an increased incidence in smokers, but is also 
the most common type of lung cancer seen in non-smokers.  
 
Adenocarcinoma of the lung tends to stain mucin positive as it is 
derived from the mucus producing glands of the lungs. Similar to 
other adenocarcinoma, if this tumor is well differentiated (low grade) it 
will resemble the normal glandular structure. Poorly 
differentiated adenocarcinoma will not resemble the normal glands 
(high grade) and will be detected by seeing that they stain positive for 
mucin (which the glands produce). 
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SQUAMOUS CELL CARCINOMA 
Squamous cell lung cancer is a form of non-small cell lung 
cancer. Squamous cell lung cancers usually begin in the bronchial tubes 
(large airways) in the central part of the lungs. 
 
Squamous Cell Carcinoma cells are large, flattened and stratified 
with a high cytoplasm to nucleus ratio. Key diagnostic features include 
the presence of intra cytoplasmic keratin which may be linked to the 
presence of intercellular bridges and squamous pearl formation. Most 
Squamous Cell Carcinomas arise centrally within the main, lobar, 
segmental or subsegmental bronchi but some occur more peripherally. 
The tumour mass generally extends into the lumen of the airway with 
invasion into the underlying wall. 
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SMALL CELL LUNG CARCINOMA  
Small cell lung cancer (SCLC) is a tumor of extremes. Untreated, 
it is one of the most highly virulent malignancies known, with a life 
expectancy best measured in days to weeks. On the other hand, it 
displays exquisite chemosensitivity, resulting in partial or complete 
responses in the vast majority of cases. Unfortunately, although many 
patients can be rendered free of clinical evidence of disease, most 
quickly relapse and die from this malignancy.  
 
Like all other lung cancers, SCLC is linked to a variety of 
environmental risk factors. By far the strongest association is with the 
use of tobacco: Up to 98 percent of SCLC patients have a history of 
smoking. Occupational risks for SCLC include exposure to 
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bischloromethyl ethers, nickel, vinyl chloride, asbestos, cadmium, and 
radon daughters (in uranium miners). Other types of radiation exposure 
also appear to be significant risk factors, with an increased incidence of 
SCLC in atomic bomb survivors and patients (typically those with 
breast cancer or Hodgkin’s lymphoma) exposed to therapeutic 
irradiation. 
OTHER RELATED STUDIES 
The study done by Biswajit Chakrabarti, MBBS, FRCP; Ida 
Ryland, MSc;John Sheard, MD, FRCPath; Christopher J. Warburton, 
MD, FRCP; and John E. Earis, MD, FRCP on “The Role of Abrams 
Percutaneous Pleural Biopsy in the Investigation of Exudative 
Pleural Effusions” says blind Abrams needle biopsy is being 
superseded by image-guided biopsies and thoracoscopy, both of which 
have been demonstrated to have a higher diagnostic yield in malignant 
disease.(26,27). On conclusion of this study (minimum of 1 year after 
biopsy), malignancy was confirmed in 46 cases (61%), of which 21 
cases (46%) were diagnosed by Abrams pleural biopsies. In the 75 
patients studied, the overall diagnostic sensitivity of initial blind biopsy 
was 38% (rising to 43% when pleural tissue was obtained), with a 
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negative predictive value of 40%. If those Abrams biopsies that failed to 
obtain pleural tissue were excluded from the study, the sensitivity for 
diagnosing malignancy increased to 51%.(Chest 2006;129;1549-1555 
DOI 10.1378/chest.129.6.1549). 
 The study done by Nadia A. Hasaneen, MD, PhD; Maysaa E. 
Zaki, MD, PhD; Hala M. Shalaby, MD; and Ahmad S. El-Morsi, MD, 
PhD on “Polymerase Chain Reaction of Pleural Biopsy Is a Rapid 
and Sensitive Method for the Diagnosis of Tuberculous Pleural 
Effusion” had the overall accuracy of PCR of pleural biopsy was 
similar to the results of pleural biopsy culture, however, PCR of the 
pleural biopsy was much faster in reaching diagnosis. PCR of pleural 
biopsy is a useful method when used in combination with the BACTEC 
culture system and histopathologic examination of pleural biopsy to 
reach a rapid diagnosis of tuberculous pleural effusion. (CHEST 2003; 
124:2105–2111 DOI 10.1378/chest.124.6.2105)  
  The study done by Renda Soylemez Wiener, MD; Phyllis Della-
Latta, PhD; and Neil W. Schluger, MD, FCCP on “Effect of Nucleic 
Acid Amplification for Mycobacterium tuberculosis on Clinical 
Decision Making in Suspected Extrapulmonary Tuberculosis” had 
the following results The NAAT proved to be a sensitive and specific 
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test for detection of M tuberculosis in extrapulmonary specimens but did 
not weigh heavily in clinical decision making at our hospital. Judicious 
use of these tests may improve the accuracy and speed of diagnosis of 
extrapulmonary tuberculosis, while helping to eliminate unnecessary 
antituberculous treatment in patients without Tuberculosis. (CHEST 
2005; 128:102–107 DOI 10.1378/chest.128.1.102)  
   The study done by W R Salyer, J C Eggleston and Y S Erozan on 
“ Efficacy of Pleural Needle Biopsy and Pleural Fluid 
Cytopathology in the Diagnosis of Malignant Neoplasm Involving 
the Pleura” has compared the efficacy of pleural needle biopsy and 
pleural fluid cytopathology in the diagnosis of pleural neoplasm 
Cytologic studies alone yielded a higher percentage of cancer diagnoses 
than did the biopsies alone. A diagnosis was established in 90 percent of 
the patients with pleural tumor when both studies were performed. 
(Chest 1975;67;536-539 DOI 10.1378/chest.67.5.536 ) 
The study conducted by Sudipta Pandit, Arunabha Datta 
Chaudhuri, Sourin Bhuniya Saikat Datta, Atin Dey, Pulakesh Bhanja at 
the Department of Chest Medicine, R.G. Kar Medical College, Kolkata, 
India on “Role of pleural biopsy in etiological diagnosis of pleural 
effusion” says Malignancy was the most common etiology, followed by 
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tuberculosis. Pleural biopsy was done in 72 patients. Pleural tissue was 
obtained in 62 cases. Malignancy was diagnosed in 24, tuberculosis in 
20 and non-specific inflammation in 18, on histopathological 
examination. Out of 20 histological proven tuberculosis cases adenosine 
de-aminase (ADA) was more than 70 u/l in 11 cases and concludes that 
malignancy is more common than tuberculosis, particularly in elderly. 
When thoracoscope is not available, pleural fluid cytology and pleural 
biopsy can give definite diagnosis. Pleural fluid ADA ≥ 70 u/l is almost 
diagnostic of tuberculosis, where pleural biopsy is not recommended.( 
Lung India, Year 2010, Volume 27, Issue 4 [p. 202-204] 
DOI: 10.4103/0970-2113.71941) 
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MATERIALS AND METHODS 
STUDY DESIGN 
This is a Prospective (Observational) study designed to evaluate 
the role of closed pleural biopsy in undiagnosed exudative Pleural 
effusion . 
STUDY CENTER 
The study was done at the Department of Thoracic Medicine – 
Government General Hospital, Chennai. 
STUDY DURATION 
January 2010 to June 2010 
STUDY POPULATION 
  Patients with exudative pleural effusion remain undiagnosed after 
pleural fluid analysis.  
Proforma was designed and ethical clearance was obtained. A 
written informed consent was obtained from all the patients included in 
the study after explaining in detail the nature and purpose of the study. 
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INCLUSION CRITERIA 
 Exudative effusion which is negative for Malignant cells, Acid 
Fast Bacillus, Gram stain and Non Tuberculous culture in Pleural 
fluid . 
EXCLUSION CRITERIA 
 Exudative effusion positive for Malignant cells 
 Exudative effusion positive for Tuberculosis in Pleural fluid 
smear 
 Exudative effusion positive for Gram stain or Non-Tuberculous 
culture 
 Parenchymal lesion in the X-ray suggestive of Tuberculosis or 
Malignancy or parapneumonic effusion 
 Uncooperative patients 
 Coagulation disorders 
 Dry pleural tapping 
 Empyema 
 Uremia  
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STUDY PROCEDURE 
Patients with undiagnosed exudative pleural effusion, fulfilling 
Inclusion criteria were admitted in Thoracic Medicine ward at 
Government General Hospital. 
Informed & Written consent obtained from the patient . 
Investigations were done to rule out Renal diseases and 
Coagulation abnormality. Pleural fluid sent for basic biochemical and 
microbiological investigations.  
Pleural biopsy was performed using ABRAM’S pleural biopsy 
needle under strict aseptic precaution under local anaesthesia and the 
specimen was sent for the following investigations 
 Tissue – Histopathological Examination 
 Tissue – Reverse Transcriptase Polymerase Chain Reaction 
for Tuberculosis.  
 Tissue – Culture for Tuberculosis by BACTEC 
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METHOD OF PLEURAL BIOPSY 
The patient was positioned, and the site was selected either 
clinically or by image guidance. The skin was cleaned, and the local 
anesthetic was administered as for diagnostic thoracentesis. Liberal 
amounts of lignocaine was injected once the rib is passed to ensure 
adequate anesthesia of the parietal pleura. 
Skin incision was made at the selected site to insert the Abram's 
pleural biopsy needle, the stylet was placed in the inner cannula, which, 
in turn, was placed in the outer trocar. The inner cannula was twisted 
clockwise to close the distal notch of the outer trocar. The needle was 
pushed into the pleural space by exerting firm pressure on the stylet. 
Because the needle has a large diameter and is blunt, a substantial 
amount of pressure was needed. Usually, a pop was heard as the needle 
enters the pleural space. The inability to pass the needle into the pleural 
space is usually because of an insufficiently large skin incision. At 
times, the ribs were too close together to allow the needle to pass. In 
such situations, rotation of the patient's arm and shoulder over his or her 
head frequently separated the ribs sufficiently. 
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 Once the tip of the needle is thought to be in the pleural space, the 
inner stylet was removed, and with the inner cannula in the closed 
position, a syringe was attached to the connection on the inner cannula. 
Then, the inner cannula was rotated counter-clockwise in the outer 
trocar so that the distal notch was locked open. At this time, pleural fluid 
was aspirated for diagnostic studies. When the desired fluid has been 
obtained, the inner cannula of the needle was rotated clockwise to 
occlude the distal notch so that the syringe can b changed without 
creating a pneumothorax. A 10- to 20-mL syringe was then attached to 
the needle, and the inner cannula was rotated to open the distal notch. 
The entire needle was then rotated so that the knob on the outer trocar 
was inferior. This was important so that the blood vessels and nerves 
that lie immediately below the rib were not biopsied. The biopsy needle 
was then slowly withdrawn with constant aspiration until it hooked onto 
the pleura . When the needle hooks, one can be sure that parietal pleura 
was in the notch of the needle if pleural fluid can still be aspirated 
through the syringe. When the needle was hooked on the pleura, the 
outer trocar was held firmly with one hand while the inner cannula was 
rotated into the closed position with the other hand to cut off a small 
piece of parietal pleura . Usually, mild resistance was met immediately 
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before the needle was completely closed, and this resistance is because 
the inner cannula severing the entrapped pleura for the biopsy specimen. 
Once the initial biopsy specimen was obtained, the needle can 
either be withdrawn from the pleural space in the closed position, the 
pleural biopsy specimen was found in the tip of the needle. Reinsertions 
of the needle are through the same tract, however, and are easier than 
the original insertion. The biopsy procedure can be repeated without 
removing the biopsy needle. Whenever the Abram's pleural biopsy 
needle was withdrawn from the pleural space, the biopsy tract was 
occluded with a finger immediately after the needle was withdrawn to 
decrease the likelihood of a pneumothorax. 
At least six separate biopsy specimens were obtained. Four were 
placed in formalin and were taken to the pathology laboratory, and the 
other two were placed in a sterile container and sent to the laboratory for 
BACTEC culture and Reverse Transcriptase Polymerase Chain Reaction 
targeting 85B gene of Mycobacterium Tuberculosis.  
Once the biopsy specimens were obtained, a therapeutic 
thoracentesis was performed through the Abram's needle. The pleural 
fluid should was removed only after obtaining the biopsy specimens 
30 
 
because the pleural fluid separates the parietal and visceral pleura, and 
increases the safety of the procedure. 
When the Abram's needle was withdrawn for the last time, the 
biopsy site was massaged for a short time to eradicate the needle tract. 
Then a small adhesive bandage was placed over the biopsy incision in a 
crosswise manner to act as a butterfly-type dressing. Chest radiographs 
were obtained on all patients after pleural biopsies. 
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TREATMENT 
 Patients with conclusive evidence of  Tuberculosis or Malignancy 
were treated  with  Anti Tuberculous Treatment in case of Tuberculosis 
and for the underlying Malignancy in case of Malignant disease . The 
patients left undiagnosed (11 out of the 51 cases) even after pleural 
biopsy were started on Anti Tuberculous Treatment and were further 
evaluated and followed up. Five out of eleven patients were found to 
have Malignancy of which two patients had a peripheral mass in the 
repeat CT chest taken after draining all the pleural fluid an CT guided 
bipsy of the mass revealed Malignancy, one patient was diagnosed by 
Thoracoscope outside our center, one was diagnosed after metastasis to 
cervical node in Fine Needle Aspiration Cytology of cervical node and 
the other patient was a case of male carcinoma breast operated 4 years 
back and completed chemotherapy and radiotherapy had a disseminated 
disease on further evaluation. The other six patients responded to Anti 
Tuberculous Treatment.   
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RESULTS 
Pleural biopsy was done in 51 patients ( 44 Males and 7 Females ) 
and the results of Histopathological Examination, BACTEC culture and 
Reverse Transcriptase Polymerase Chain Reaction on the pleural biopsy 
specimens were analysed and the results of which were as follows . 
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AGE & SEX DISTRIBUTION 
YEARS  19-35 yrs  36-50 yrs  >50 yrs  
MALE 18  8  18  
FEMALE 3  1  3  
During the study period of 6 months, Pleural biopsy was done in 
51 patients of undiagnosed exudative effusions out of which there were 
7 females and 44 males. There is a clear male predominance with the 
incidence more in Younger age and Elder age and a relatively lower 
incidence in middle age group . 
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YIELD OF HPE IN PLEURAL BIOPSY 
Histopathological Examination diagnosed 45.1% of biopsy 
specimens as Tuberculosis and 23.5% as Malignancy. The rest 31.4% of 
case were left undiagnosed after Histopathological Examination of 
Pleural biopsy. 
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HPE 
FREQUENCY 
(n=51) 
PERCENT 
TUBERCULOSIS 23 45.1% 
MALIGNANCY 12 23.5% 
UNDIAGNOSED 16 31.4% 
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RTPCR IN PLEURAL BIOPSY 
RTPCR FREQUENCY 
(n=51) 
PERCENTAGE 
POSITIVE 9 17.6% 
NEGATIVE 42 82.4% 
Reverse Transcriptase Polymerase Chain Reaction was positive in 
17.6% of the cases and was negative in 82.4% of the cases ( That is 9 
out of the 51 cases were positive for RTPCR ). 
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BACTEC IN PLEURAL BIOPSY 
BACTEC FREQUENCY 
(n=51) 
PERCENTAGE 
POSITIVE 4 7.84% 
NEGATIVE 47 92.16% 
BACTEC was able to diagnose only 4 cases in the pleural biopsy 
specimens. BACTEC was positive in 7.84% of the cases and was 
negative in92.16% of the cases. 
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INCIDENCE OF PLEURAL MALIGNANCIES 
HPE 
FREQUENCY 
(n=12) 
PERCENT
ADENOCARCINOMA 6 50% 
SQUAMOUS CELL CARCINOMA 4 33.33% 
LYMPHOMA 1 8.33% 
SMALL CELL CARCINOMA 1 8.33% 
Out of the malignancies proved in the study Adenocarcinoma 
topped the list with 50% followed by Squamous cell carcinoma with 
33.33% and then by Lymphoma and Small cell carcinoma with 8.33% 
each. 
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YIELD OF PLEURAL BIOPSY 
 RESULTS  19-35 
yrs  
35-50 
yrs  
>50 yrs  
MALE  TUBERCULOSIS  16  4  4  
MALIGNANCY  0  1  9  
UNDIAGNOSED  2  3  5  
FEMALE  TUBERCULOSIS  2  1  1  
MALIGNANCY  0  0  2  
UNDIAGNOSED  1  0  0  
 TOTAL   21  9  21  
 
This clearly shows that Tuberculous Pleural effusion is more 
common in the Younger age group and Malignant Pleural effusion more 
common in the Elder age in both males and females. 
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CASES DIAGNOSED BY PLEURAL BIOPSY 
COMBINING HPE , 
BACTEC &RTPCR  
FREQUENCY 
(n=51)  
PERCENT 
%  
DIAGNOSED 40  78.5%  
UNDIAGNOSED 11  21.5%  
About 78.5% of cases were diagnosed when combining 
Histopathological Examination, BACTEC culture and Reverse 
Transcriptase Polymerase Chain Reaction on Pleural biopsy specimen. 
21.5% of cases were left undiagnosed even after combining all the three 
tests. 
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FOLLOW UP . . . 
  Five out of the eleven patients left undiagnosed after pleural 
biopsy were found to have Malignancies . The other six responded to 
Anti-Tuberculous Treatment. 
 The study population was divided into two groups of Tuberculous 
Pleural Effusion and Malignant Pleural Effusion based on the final 
diagnosis and the yield of each test in Tuberculous and Malignant 
effusion are discussed separately as follows. 
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YIELD OF HPE IN TUBERCULOUS EFFUSION 
HPE 
FREQUENCY 
(n=34) 
PERCENT 
% 
TUBERCULOSIS 23 67.6% 
NEGATIVE 11 32.4% 
Histopathological Examination was able to diagnose 67.6% of 
Tuberculous cases and was Non-diagnostic in 32.4% of the Tuberculous 
cases. 
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YIELD OF BACTEC IN MYCOBACTERIAL INFECTION 
BACTEC  FREQUENCY 
(n=34)  
PERCENT 
%  
POSITIVE  4  11.8%  
NEGATIVE  30  88.2%  
BACTEC culture was able to diagnose only 11.8% of 
Tuberculous cases and was Non-diagnostic in 88.2% of the Tuberculous 
cases. 
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YIELD OF BACTEC IN MYCOBACTERIAL INFECTION 
 BACTEC was able to diagnose a case of Pleural effusion due to 
Non-Tuberculous Mycobacterium (Mycobacterium fortuitum). The 
patient started on Category-I Anti Tuberculous Treatment along with 
Macrolides. The patient improved well . 
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YIELD OF RTPCR IN TUBERCULOUS EFFUSION 
 RTPCR  FREQUENCY 
(n=34)  
PERCENT  
POSITIVE 9  26.1%  
NEGATIVE 27  73.9%  
RTPCR was able to diagnose 26.1% of Tuberculous cases and 
was Non-diagnostic in 73.9% of the Tuberculous cases. 
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YIELD OF HPE IN MALIGNANT PLEURAL EFFUSION 
HPE  FREQUENCY 
 (n=17)  
PERCENT 
%  
DIAGNOSED 12  70.6%  
NEGATIVE 5  29.4%  
Histopathological Examination diagnosed 70.6% of malignant 
cases and only 29.4% needed further evaluation to prove their 
malignancy. 
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SENSITIVITY AND SPECIFICITY 
HISTOPATHOLOGICAL EXAMINATION 
HPE 
TUBERCULOUS 
CASES 
NON-TUBERCULOUS 
CASES 
POSITIVE 23 0 
NEGATIVE 11 17 
 
HISTOPATHOLOGICAL 
EXAMINATION 
PERCENTAGE 
SENSITIVITY 67.64% 
SPECIFICITY 100% 
POSITIVE PREDICTIVE VALUE 100% 
NEGATIVE PREDICTIVE VALUE 60.71% 
There were no False positive results with Histopathological 
Examination making the Specificity and Positive predictive value as 
100%. The Sensitivity was 67.64% and Negative predictive value was 
60.71%. 
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SENSITIVITY AND SPECIFICITY 
BACTEC 
BACTEC 
TUBERCULOUS 
CASES 
NON-TUBERCULOUS 
CASES 
POSITIVE 4 0 
NEGATIVE 30 17 
 
BACTEC PERCENTAGE 
SENSITIVITY 11.8% 
SPECIFICITY 100% 
POSITIVE PREDICTIVE VALUE 100% 
NEGATIVE PREDICTIVE VALUE 36.17% 
There were no False positive results with BACTEC culture 
making the Specificity and Positive predictive value as 100%. The 
Sensitivity was only 11.8% and Negative predictive value was 36.17%. 
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SENSITIVITY AND SPECIFICITY 
RTPCR 
RTPCR 
TUBERCULOUS 
CASES 
NON-TUBERCULOUS 
CASES 
POSITIVE 9 0 
NEGATIVE 25 17 
 
RTPCR PERCENTAGE 
SENSITIVITY 26.47% 
SPECIFICITY 100% 
POSITIVE PREDICTIVE VALUE 100% 
NEGATIVE PREDICTIVE VALUE 40.47% 
There were no False positive results with RTPCR making the 
Specificity and Positive predictive value as 100%. The Sensitivity was 
26.47%(much higher than BACTEC) and Negative predictive value was 
40.47%. 
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SENSITIVITY AND SPECIFICITY 
HISTOPATHOLOGICAL EXAMINATION 
HPE 
MALIGNANT   
CASES 
NON- MALIGNANT 
 CASES 
POSITIVE 12 0 
NEGATIVE 5 34 
 
HISTOPATHOLOGICAL 
EXAMINATION 
PERCENTAGE 
SENSITIVITY 70.6% 
SPECIFICITY 100% 
POSITIVE PREDICTIVE VALUE 100% 
NEGATIVE PREDICTIVE VALUE 87.17% 
There were no False positive results with Histopathological 
Examination making the Specificity and Positive predictive value as 
100%. The Sensitivity was 70.6% and Negative predictive value was 
87.17%. 
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DISCUSSION 
Needle biopsy of the pleura can establish the diagnosis of a 
malignant pleural effusion. The percentage of positive pleural biopsies 
in patients with malignant pleural disease ranges from 39% to 75%. In 
general, pleural fluid cytology is superior to pleural biopsy in 
establishing the diagnosis of pleural malignancy. The diagnostic yield of 
Pleural biopsy in our study was 70% in Malignant cases.  
In one study of 248 patients with tuberculous pleuritis who 
underwent needle biopsy of the pleura, the biopsy showed granulomas 
in 198 patients (80%), the acid-fast stain of the biopsy was positive in 
64 (25.8%), the culture of the biopsy tissue was positive in 140 (56%), 
and at least one of the preceding three tests was positive in 227 (91%) 
(28). Polymerase Chain Reaction has also been tried on pleural biopsy 
specimens but it is not clear that the Polymerase Chain Reaction adds to 
the regular microscopic examination (29). In our study 
Histopathological examination diagnosed 67% of Tuberculous effusion . 
Reverse Transcriptase Polymerase Chain Reaction diagnosed 26.1% of 
Tuberculous effusion. BACTEC diagnosed 11.8% of Tuberculous 
effusion . 82.3% of Tuberculous cases were diagnosed by combining all 
three tests .  
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As there were no false positive results with any of the three tests 
(Histopathological examination, Reverse Transcriptase Polymerase 
Chain Reaction and BACTEC culture), they are highly Specific in 
diagnosing both Tuberculosis and malignancy. Both the Specificity and 
Positive predictive value were 100% with these tests. As these tests are 
highly specific we can start treatment even when any of these test is 
positive . 
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CLINICAL IMPLICATION 
 Closed Pleural Biopsy can be used as a easy, quick, cost effective 
and relatively safe method to diagnose an exudative effusion not 
diagnosed by pleural fluid analysis. 
  No complications occurred during the procedure except for a 
single case of Vasovagal shock (recovered). 
 No post-procedure complications (such as Pneumothorax, 
hemorrhage or Infections of the pleural space).  
 Results of Reverse Transcriptase Polymerase Chain Reaction are 
available within 24 hours and treatment can be initiated readily . 
 BACTEC culture detects both Mycobacterium Tuberculosis and 
Non Tuberculous Mycobacterium . 
 Resistance pattern of Mycobacterium Tuberculosis can be 
assessed by both BACTEC culture and Genetic analysis of the 
DNA detected using Reverse Transcriptase Polymerase Chain 
Reaction .  
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 Reverse Transcriptase Polymerase Chain Reaction targeting 85 B 
gene is very specific for Mycobacterium tuberculosis , so that it is 
negative for Non-Tuberculous Mycobacterium. 
 m-RNA detected by Reverse Transcriptase Polymerase Chain 
Reaction has a half life for only few minutes and can detect only 
viable Mycobacterium . 
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CONCLUSION 
 Combination of Histopathological examination, BACTEC culture 
and Reverse Transcriptase Polymerase Chain Reaction in closed 
Pleural biopsy has a greater diagnostic yield in diagnosing 
exudative effusions not diagnosed by Pleural fluid analysis . 
 Histopathological examination diagnosed 67% of Tuberculous 
effusion .  
 Reverse Transcriptase Polymerase Chain Reaction diagnosed 
26.1% of Tuberculous effusion .  
 BACTEC diagnosed 11.8% of Tuberculous effusion . 
 Histopathological examination diagnosed 70% of Malignant 
effusion . 
 82.3% of Tuberculous cases were diagnosed by combining all 
three tests .  
 82.3% of Tuberculous cases were diagnosed by combining 
Histopathological examination and Reverse Transcriptase 
Polymerase Chain Reaction . 
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 Pleural biopsy diagnosed 79% of undiagnosed effusion . 
 Closed Pleural Biopsy can be used as a easy, quick, cost effective 
and relatively safe method to diagnose an exudative effusion not 
diagnosed by pleural fluid analysis. 
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